The FDA approved Daybue Stix, a powder formulation of trofinetide, for Rett syndrome in patients 2 years or older. New formulation, same clinical expectations: The FDA approval of DAYBUE STIX provides ...

Berotralstat becomes the first targeted oral prophylactic therapy for patients with HAE 2 years or older. The rare, inherited disease is characterized by unpredictable, potentially life-threatening ...

This approval of gepotidacin is the first in a new antibiotic class for the treatment of gonorrhoea approved in over 3 decades. Phase 3 data demonstrated noninferiority to ceftriaxone plus ...

“We took a different approach by looking at colonizing bacteria and we found vaccination reduced antimicrobial resistance through a completely different mechanism," said Brooke Ramay, lead author of ...

The FDA approved omidubicel on December 8, 2025, the same day parent company Ayrmid announced positive results at the 2025 American Society of Hematology Annual Meeting and Exposition. FDA approved ...

Strategic Alliance Partnership | Contemporary Pediatrics connects pediatricians with peer-reviewed articles, guideline updates, and practice strategies for real-world clinical application.

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis. His vital signs in clinic were within normal limits, and ...

For over 100 years, type 1 diabetes (T1D) has traditionally been diagnosed and treated at the onset of symptomatic hyperglycemia, often accompanied by severe disease, including life-threatening ...